Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F List

Showing results (41-50 of 212) with videos related to

Pageof 22
Sort By:
Expert Review of Hematology|October 3, 2013
Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?Vu H Duong, Eric Padron, Alan F List, et al.
Haematologica|October 24, 2009
Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysisAmbuj Kumar, Alan F List, Iztok Hozo, et al.
Best Practice & Research. Clinical Haematology|February 11, 2014
Deletion 5q MDS: molecular and therapeutic implicationsRami S Komrokji, Eric Padron, Benjamin L Ebert, et al.
Leukemia & Lymphoma|December 15, 2016
The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implicationsLing Zhang, Kathy L McGraw, David A Sallman, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Myelodysplastic syndromeGhulam Mufti, Alan F List, Steven D Gore, et al.
Leukemia Research|August 20, 2011
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
Myelodysplastic syndromesAlan F List, James Vardiman, Jean-Pierre J Issa, et al.
Blood|May 3, 2011
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registriesChristopher R Cogle, Benjamin M Craig, Dana E Rollison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Underreporting of myeloid malignancies by United States cancer registriesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Leukemia Research|November 25, 2016
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)Antonio Almeida, Pierre Fenaux, Alan F List, et al.
Pageof 22

Showing results (41-50 of 212) with videos related to

Sort By:
Pageof 22
Expert Review of Hematology|October 3, 2013
Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?Vu H Duong, Eric Padron, Alan F List, et al.
Haematologica|October 24, 2009
Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysisAmbuj Kumar, Alan F List, Iztok Hozo, et al.
Best Practice & Research. Clinical Haematology|February 11, 2014
Deletion 5q MDS: molecular and therapeutic implicationsRami S Komrokji, Eric Padron, Benjamin L Ebert, et al.
Leukemia & Lymphoma|December 15, 2016
The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implicationsLing Zhang, Kathy L McGraw, David A Sallman, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Myelodysplastic syndromeGhulam Mufti, Alan F List, Steven D Gore, et al.
Leukemia Research|August 20, 2011
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
Myelodysplastic syndromesAlan F List, James Vardiman, Jean-Pierre J Issa, et al.
Blood|May 3, 2011
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registriesChristopher R Cogle, Benjamin M Craig, Dana E Rollison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Underreporting of myeloid malignancies by United States cancer registriesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Leukemia Research|November 25, 2016
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)Antonio Almeida, Pierre Fenaux, Alan F List, et al.
Pageof 22